Practice guidelines for the management of infectious diarrhea RL Guerrant, T Van Gilder, TS Steiner, NM Thielman, L Slutsker, ... Clinical infectious diseases 32 (3), 331-351, 2001 | 1657 | 2001 |
Strategies to prevent surgical site infections in acute care hospitals: 2014 update DJ Anderson, K Podgorny, SI Berríos-Torres, DW Bratzler, EP Dellinger, ... Infection Control & Hospital Epidemiology 35 (S2), S66-S88, 2014 | 1600 | 2014 |
The Infectivity of Cryptosporidium parvum in Healthy Volunteers HL DuPont, CL Chappell, CR Sterling, PC Okhuysen, JB Rose, ... New England journal of medicine 332 (13), 855-859, 1995 | 1388 | 1995 |
Pathogenesis of Escherichia coli Diarrhea HL DuPont, SB Formal, RB Hornick, MJ Snyder, JP Libonati, DG Sheahan, ... New England Journal of Medicine 285 (1), 1-9, 1971 | 910 | 1971 |
Inoculum size in shigellosis and implications for expected mode of transmission HL DuPont, MM Levine, RB Hornick, SB Formal The Journal of infectious diseases 159 (6), 1126-1128, 1989 | 838 | 1989 |
Systematic review: the use of proton pump inhibitors and increased susceptibility to enteric infection C Bavishi, HL Dupont Alimentary pharmacology & therapeutics 34 (11‐12), 1269-1281, 2011 | 719 | 2011 |
Typhoid fever: pathogenesis and immunologic control H RB N Engl J Med 283, 686-691, 1970 | 705 | 1970 |
Fecal microbiota transplantation for refractory immune checkpoint inhibitor-associated colitis WDH Wang, Y Nature Med, 2018 | 682 | 2018 |
Fecal microbiota transplantation for refractory immune checkpoint inhibitor-associated colitis Y Wang, DH Wiesnoski, BA Helmink, V Gopalakrishnan, K Choi, ... Nature Med 24 (12), 1804-1808, 2018 | 670 | 2018 |
Fecal microbiota transplantation for refractory immune checkpoint inhibitor-associated colitis Nature Med 24 (12), 1804-1808, 2018 | 670 | 2018 |
Virulence of Three Distinct Cryptospovidium parvum Isolates for Healthy Adults PC Okhuysen, CL Chappell, JH Crabb, CR Sterling, HL DuPont The Journal of infectious diseases 180 (4), 1275-1281, 1999 | 639 | 1999 |
Infections due to gram-negative organisms: an analysis of 860 patients with bacteremia at the University of Minnesota Medical Center, 1958–1966 HL DuPONT, WW SPINK Medicine 48 (4), 307-332, 1969 | 564 | 1969 |
ACG clinical guideline: diagnosis, treatment, and prevention of acute diarrheal infections in adults MS Riddle, HL DuPont, BA Connor Official journal of the American College of Gastroenterology| ACG 111 (5 …, 2016 | 531 | 2016 |
Prevention and treatment of traveler's diarrhea HL DuPont, CD Ericsson New England Journal of Medicine 328 (25), 1821-1827, 1993 | 484 | 1993 |
Meta-analysis to assess risk factors for recurrent Clostridium difficile infection KW Garey, S Sethi, Y Yadav, HL DuPont Journal of Hospital infection 70 (4), 298-304, 2008 | 482 | 2008 |
Comparison of three agents of acute infectious nonbacterial gastroenteritis by cross-challenge in volunteers RG Wyatt, R Dolin, NR Blacklow, HL DuPont, RF Buscho, TS Thornhill, ... Journal of Infectious Diseases 129 (6), 709-714, 1974 | 453 | 1974 |
Adverse effect of lomotil therapy in shigellosis HL DuPont, RB Hornick Jama 226 (13), 1525-1528, 1973 | 439 | 1973 |
The intestinal microbiota and chronic disorders of the gut AW DuPont, HL DuPont Nature reviews Gastroenterology & hepatology 8 (9), 523-531, 2011 | 433 | 2011 |
Traveler’s diarrhea: a clinical review R Steffen, DR Hill, HL DuPont Jama 313 (1), 71-80, 2015 | 418 | 2015 |
Fecal leukocytes in diarrheal illness JC HARRIS, HL DUPONT, RB HORNICK Annals of internal medicine 76 (5), 697-703, 1972 | 414 | 1972 |